LGND: Zimmermann Martine discloses securities transactions
By AlphaYouPublished Form 4
Zimmermann Martine
Reporting filer
Zimmermann Martine reported Tax/exercise withholding in LIGAND PHARMACEUTICALS INC: 115 units of Common Stock, dated 2026-09-22. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 24, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Zimmermann Martine | 2026-09-22 | F | Tax/exercise withholding | 115 | 298.5 | 3,782 | 2 days | Filed terms
|
Common Stock
- Owner
- Zimmermann Martine
- Date
- 2026-09-22
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 115
- Price
- 298.5
- Following holdings
- 3,782
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-22
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: 0
- transaction Shares: 115
- id: F1
- transaction Price Per Share: 298.5
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 3782
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Zimmermann Martine: Director.
- F1: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
Original sources
Prepared automatically from public filing data. Report a correction.